Plain Language Summary: Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE

Ngan Thi Tran, Pakawit Lerksaipheng, Pranee Sutcharitchan, Ponlapat Rojnuckarin, Ken-ichi Yamada, Noppawan Phumala Morales, Rataya Luechapudiporn

Article Type

Plain Language Summary

Published

What is β-thalassaemia? β-Thalassaemia is a genetic blood disorder that can cause serious health problems, including an excess of iron in the body. This excess iron can lead to oxidative stress, which is like rust forming in your body and can damage important fats called LDL (low-density lipoprotein, or ‘bad cholesterol’). This damage can increase […]

Read more

Plain Language Summary: Biologics and small molecules for psoriasis: current and future progress

Luca Potestio, Nello Tommasino, Michela D’Agostino, Valeria Esposito, Giuseppe Lauletta, Antonio Portarapillo, Matteo Megna

Article Type

Plain Language Summary

Published

What is psoriasis? Psoriasis is a common, chronic skin disease that significantly affects the quality of life of those who have it due to red, scaly patches on the skin and associated health issues like psoriatic arthritis and heart disease. While the exact cause isn’t known, the IL-17–IL-23 axis – a pathway that drives chronic […]

Read more

Plain Language Summary: N-acetylcysteine in paediatrics: a review of efficacy, safety and dosing strategies in respiratory care

Francesca Benedetti, Pierachille Santus

Article Type

Plain Language Summary

Published

What is N-acetylcysteine? N-acetylcysteine (NAC) is a medication often used to help people with lung conditions that involve thick mucus such as bronchitis, pneumonia and cystic fibrosis. It works by thinning mucus, making it easier to clear from the lungs. It also has other helpful effects, for example, it can reduce inflammation, protect lung tissue […]

Read more

Plain Language Summary: Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies

Leonid Shunyakov, Firas B Badin, Judith Hafer, David König, Patrizia Froesch, Laurent Greillier

Article Type

Plain Language Summary

Published

Background About 2 out of 3 individuals who present to a doctor with symptoms of small cell lung cancer (SCLC) will be diagnosed with advanced disease. Standard treatment with platinum-etoposide plus atezolizumab or durvalumab is highly effective; however, virtually all patients who respond to this primary (first-line) treatment will become resistant to platinum and relapse. […]

Read more

Plain Language Summary: JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review

Beatriz Henriques dos Santos, João Domingues, Marco Sousa, Tiago Torres

Article Type

Plain Language Summary

Published

Palmoplantar pustulosis (PPP) is a chronic, inflammatory skin disease characterized by sterile pustules on the palms and/or soles. These lesions often fissure, causing significant pain, functional impairment and reduced quality of life. The disease predominantly affects women in middle age and is strongly associated with smoking. PPP is challenging to treat as it often responds […]

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.